M&A Deal Summary |
|
---|---|
Date | 2013-08-28 |
Target | Boca Pharmacal |
Sector | Medical Products |
Buyer(s) | Endo International |
Deal Type | Add-on Acquisition |
Deal Value | 225M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1920 |
Sector | Medical Products |
Employees | 3,103 |
Revenue | 2.9B USD (2020) |
Endo International is a pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, bladder cancer, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Endo International was incorporatted in 1920 and is based in Dublin, Ireland.
DEAL STATS | # |
---|---|
Overall | 10 of 16 |
Sector (Medical Products) | 5 of 5 |
Type (Add-on Acquisition) | 10 of 15 |
State (Florida) | 1 of 1 |
Country (United States) | 9 of 14 |
Year (2013) | 2 of 2 |
Size (of disclosed) | 9 of 14 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-05-11 |
Paladin Labs
Saint-Laurent, Quebec, Canada Paladin Labs, Inc., is a pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. |
Buy | $1.6B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-02-03 |
HealthTronics
Austin, Texas, United States HealthTronics provides mobile equipment services, medical devices and information technology solutions to the urology industry. The company partners with physician groups to facilitate equipment ownership and to provide logistical support for mobile lithotripsy, laser and cryoablation units. In addition, HealthTronics offers a line of cryoablation devices as well as a urology-specific IT platform. HealthTronics was founded in 1972 and is based in Austin, Texas. |
Sell | $130M |